View Item 

Show simple item record

Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation

dc.contributor.authorPersaud, Yogindra
dc.contributor.authorSeddiq, Marjilla
dc.contributor.authorWu, Yi‐mi
dc.contributor.authorRobinson, Dan R.
dc.contributor.authorPoulik, Janet
dc.contributor.authorAltinok, Deniz
dc.contributor.authorRoarty, John D.
dc.contributor.authorMody, Rajen
dc.contributor.authorTaub, Jeffrey W.
dc.date.accessioned2021-07-01T20:10:52Z
dc.date.available2022-09-01 16:10:51en
dc.date.available2021-07-01T20:10:52Z
dc.date.issued2021-08
dc.identifier.citationPersaud, Yogindra; Seddiq, Marjilla; Wu, Yi‐mi ; Robinson, Dan R.; Poulik, Janet; Altinok, Deniz; Roarty, John D.; Mody, Rajen; Taub, Jeffrey W. (2021). "Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation." Pediatric Blood & Cancer 68(8): n/a-n/a.
dc.identifier.issn1545-5009
dc.identifier.issn1545-5017
dc.identifier.urihttps://hdl.handle.net/2027.42/168275
dc.publisherWiley Periodicals, Inc.
dc.titleUnusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPediatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168275/1/pbc29064.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168275/2/pbc29064_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168275/3/pbc29064-sup-0001-SuppMat.pdf
dc.identifier.doi10.1002/pbc.29064
dc.identifier.sourcePediatric Blood & Cancer
dc.identifier.citedreferenceAguirre- Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007; 7 ( 11 ): 834 - 846.
dc.identifier.citedreferenceCicinelli MV, Kaliki S. Orbital relapse of retinoblastoma in patients with high- risk histopathology features. Ther Adv Ophthalmol. 2019; 11: 2515841419844080.
dc.identifier.citedreferenceKaliki S, Srinivasan V, Gupta A, Mishra DK, Naik MN. Clinical features predictive of high- risk retinoblastoma in 403 Asian Indian patients. Ophthalmology. 2015; 122 ( 6 ): 1165 - 1172.
dc.identifier.citedreferenceHonavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high- risk retinoblastoma. Arch Ophthalmol. 2002; 120 ( 7 ): 923 - 931.
dc.identifier.citedreferenceKopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987; 94 ( 4 ): 371 - 377.
dc.identifier.citedreferenceChévez- Barrios P, Eagle RC, Krailo M, et al. Study of unilateral retinoblastoma with and without histopathologic high- risk features and the role of adjuvant chemotherapy: a Children’s Oncology Group Study. J Clin Oncol. 2019; 37 ( 31 ): 2883 - 2891.
dc.identifier.citedreferenceKaliki S, Shields CL, Rojanaporn D, et al. High- risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes. Ophthalmology. 2013; 120 ( 5 ): 997 - 1003.
dc.identifier.citedreferenceChantada GL, de Dávila MT, Fandiño A, et al. Retinoblastoma with low risk for extraocular relapse. Ophthalmic Genet. 1999; 20 ( 3 ): 133 - 140.
dc.identifier.citedreferenceMody RJ, Wu YM, Lonigro RJ, et al. Integrative clinical sequencing in the management of refractory or relapsed cancer in youth. JAMA. 2015; 314 ( 9 ): 913 - 925.
dc.identifier.citedreferenceAfshar AR, Pekmezci M, Bloomer MM, et al. Next- generation sequencing of retinoblastoma identifies pathogenic alterations beyond RB1 inactivation that correlate with aggressive histopathologic features. Ophthalmology. 2020; 127 ( 6 ): 804 - 813.
dc.identifier.citedreferenceKooi IE, Mol BM, Massink MP, et al. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Sci Rep. 2016; 6: 25264.
dc.identifier.citedreferenceAlimirah F, Pulido T, Valdovinos A, et al. Cellular senescence promotes skin carcinogenesis through p38MAPK and p44/42MAPK signaling. Cancer Res. 2020; 80 ( 17 ): 3606 - 3619.
dc.identifier.citedreferenceDemaria M, O’Leary MN, Chang J, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 2017; 7 ( 2 ): 165 - 176.
dc.identifier.citedreferenceNeophytou CM, Kyriakou TC, Papageorgis P. Mechanisms of metastatic tumor dormancy and implications for cancer therapy. Int J Mol Sci. 2019; 20 ( 24 ): 6158.
dc.identifier.citedreferenceTamamori- Adachi M, Koga A, Susa T, et al. DNA damage response induced by etoposide promotes steroidogenesis via GADD45A in cultured adrenal cells. Sci Rep. 2018; 8: 9636.
dc.identifier.citedreferenceKitawaki Y, Nakamura Y, Kubota- Nakayama F, et al. Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol- producing adrenocortical adenoma. Hum Pathol. 2018; 77: 88 - 97.
dc.identifier.citedreferencePaez D, Labonte MJ, Bohanes P, et al. Cancer dormancy: a model of early dissemination and late cancer recurrence. Clin Cancer Res. 2011; 18 ( 3 ): 645 - 653.
dc.identifier.citedreferenceEndo H, Inoue M. Dormancy in cancer. Cancer Sci. 2019; 110: 474 - 480.
dc.identifier.citedreferenceBulavin DV, Fornace AJ. p38 MAP kinase’s emerging role as a tumor suppressor. Adv Cancer Res. 2004; 92: 95 - 118.
dc.identifier.citedreferencePicarda E, Ohaegbulam KC, Zang X. Molecular pathways: targeting B7- H3 (CD276) for human cancer immunotherapy. Clin Cancer Res. 2016; 22 ( 14 ): 3425 - 3431.
dc.identifier.citedreferenceXu S, Zhao F, Liang Z, et al. Expression of FANCD2 is associated with prognosis in patients with nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2019; 12 ( 9 ): 3465 - 3473.
dc.identifier.citedreferenceKomatsu H, Masuda T, Iguchi T, et al. Clinical significance of FANCD2 gene expression and its association with tumor progression in hepatocellular carcinoma. Anticancer Res. 2017; 37 ( 3 ): 1083 - 1090.
dc.identifier.citedreferenceGuo Y, Rehati A, Wu Z, Zhang W, Zhuang P, He F. A novel function of CYP21A2 in regulating cell migration and invasion via Wnt signaling. Gen Physiol Biophys. 2020; 39 ( 4 ): 373 - 381.
dc.identifier.citedreferenceShields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control. 2004; 11 ( 5 ): 317 - 327.
dc.identifier.citedreferenceHu H, Zhang W, Wang Y, et al. Characterization, treatment and prognosis of retinoblastoma with central nervous system metastasis. BMC Ophthalmol. 2018; 18: 107.
dc.identifier.citedreferenceChantada GL, Dunkel IJ, Antoneli CB, et al. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Pediatr Blood Cancer. 2007; 49 ( 3 ): 256 - 260.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
pbc29064.pdf
Size:
478.9KB
Format:
PDF
View/Open
Name:
pbc29064_am.pdf
Size:
691.1KB
Format:
PDF
View/Open
Name:
pbc29064-sup-0001-SuppMat.pdf
Size:
216.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.